Newsletter May 2020 No.197
Top News
On February 14, 2020, the "2020 Life Science Intellectual Property Forum" was held at the Sola City Conference Center (Chiyoda-ku, Tokyo), hosted by the Pharmaceutical Manufacturers Association and supported by the Bioindustry Association of Japan. The theme of the forum was "How to protect new businesses that use digital data as a source of value: Multifaceted protection through intellectual property and contracts. The seminar featured lectures and discussions by experts representing industry, academia, and government on the industrial policy aspects. In addition to the protection and handling of the raw data of measurement results provided by users in such business models, there was a lively discussion on the secondary use of data and the protection and handling of the results obtained as a result of such use. In addition to the protection and handling of the raw data of measurement results provided by users, there was a lively discussion on the secondary use of data and the protection and handling of results obtained as a result of the use. This report provides an overview of the lectures and panel discussions.
Topics
- The "Pharmaceutical Manufacturers Association of Japan Media Forum" will be held.
The theme is "Trends in the Personal Information Protection Law Revision and the Legislative Policy for Medical Information - The 8th Symposium of the Pharmaceutical Affairs Committee held
- Study Group on Response to Pharmaceutical Consultation 2020
"Pharmaceutical Association of Japan Forum on Response to Pharmaceutical Consultation - Pharmaceutical Association of Japan Special Program KRY Yamaguchi Broadcasting
"Yamaguchi! Buchi genki! ～The open recording of the program "Yamaguchi!
Policy Research Institute page
Thinking about the ecosystem in the healthcare sector
Discussion Points on the Data Ecosystem
From JPMA
Message from the President of the Pharmaceutical Manufacturers Association of Japan